These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19559599)

  • 1. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
    Lee JE; Saphire EO
    Curr Opin Struct Biol; 2009 Aug; 19(4):408-17. PubMed ID: 19559599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
    J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope.
    West BR; Moyer CL; King LB; Fusco ML; Milligan JC; Hui S; Saphire EO
    mBio; 2018 Sep; 9(5):. PubMed ID: 30206174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for differential neutralization of ebolaviruses.
    Bale S; Dias JM; Fusco ML; Hashiguchi T; Wong AC; Liu T; Keuhne AI; Li S; Woods VL; Chandran K; Dye JM; Saphire EO
    Viruses; 2012 Apr; 4(4):447-70. PubMed ID: 22590681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State.
    Lappala A; Nishima W; Miner J; Fenimore P; Fischer W; Hraber P; Zhang M; McMahon B; Tung CS
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29748487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice.
    Chen T; Li D; Song Y; Yang X; Liu Q; Jin X; Zhou D; Huang Z
    Antiviral Res; 2017 Sep; 145():54-59. PubMed ID: 28733113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
    Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ
    J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on ebola virus glycoprotein].
    Ding GY; Wang ZY; Gao L; Jiang BF
    Bing Du Xue Bao; 2013 Mar; 29(2):233-7. PubMed ID: 23757858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational Dynamics.
    Durham ND; Howard AR; Govindan R; Senjobe F; Fels JM; Diehl WE; Luban J; Chandran K; Munro JB
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving cross-reactivity with pan-ebolavirus antibodies.
    King LB; Milligan JC; West BR; Schendel SL; Ollmann Saphire E
    Curr Opin Virol; 2019 Feb; 34():140-148. PubMed ID: 30884329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design.
    Khurana S; Ravichandran S; Hahn M; Coyle EM; Stonier SW; Zak SE; Kindrachuk J; Davey RT; Dye JM; Chertow DS
    Cell Host Microbe; 2020 Feb; 27(2):262-276.e4. PubMed ID: 32053790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.
    Bale S; Liu T; Li S; Wang Y; Abelson D; Fusco M; Woods VL; Saphire EO
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1395. PubMed ID: 22102923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of broad ebolavirus neutralization by a human survivor antibody.
    West BR; Wec AZ; Moyer CL; Fusco ML; Ilinykh PA; Huang K; Wirchnianski AS; James RM; Herbert AS; Hui S; Goodwin E; Howell KA; Kailasan S; Aman MJ; Walker LM; Dye JM; Bukreyev A; Chandran K; Saphire EO
    Nat Struct Mol Biol; 2019 Mar; 26(3):204-212. PubMed ID: 30833785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk.
    King LB; West BR; Moyer CL; Gilchuk P; Flyak A; Ilinykh PA; Bombardi R; Hui S; Huang K; Bukreyev A; Crowe JE; Saphire EO
    Nat Commun; 2019 Apr; 10(1):1788. PubMed ID: 30996276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for Marburg virus neutralization by a cross-reactive human antibody.
    Hashiguchi T; Fusco ML; Bornholdt ZA; Lee JE; Flyak AI; Matsuoka R; Kohda D; Yanagi Y; Hammel M; Crowe JE; Saphire EO
    Cell; 2015 Feb; 160(5):904-912. PubMed ID: 25723165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.
    Shedlock DJ; Bailey MA; Popernack PM; Cunningham JM; Burton DR; Sullivan NJ
    Virology; 2010 Jun; 401(2):228-35. PubMed ID: 20304456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.
    Marzi A; Wegele A; Pöhlmann S
    Virology; 2006 Sep; 352(2):345-56. PubMed ID: 16777170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.